I plan on posting links to abstracts from the following: YMI, PCYC, ARIA, CYTR, CELG, INCY, ONXX. Are there any other companies people would like posted?
The Novel KSP Inhibitor ARRY-520 Demonstrates Single-Agent Activity in Refractory Myeloma: Results From a Phase 2 Trial in Patients with Relapsed/Refractory Multiple Myeloma (MM) http://ash.confex.com/ash/2011/webprogram/Paper40171.html